Kiniksa Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Kiniksa Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Kiniksa Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kiniksa Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.5M | 259k | 17.54 |
| 2023-09-30 | $4.5M | 257k | 17.37 |
| 2023-06-30 | $2.3M | 161k | 14.08 |
| 2023-03-31 | $434k | 40k | 10.76 |
| 2022-12-31 | $335k | 22k | 14.98 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management